Arthrilab will provide a method to early diagnose the public health disease, osteoarthritis(OA). With our patent pending technology we aim to create a diagnostic tool in order to detect OA in various stages and track progress in combination with treatment. Arthrilab’s vision is to support actors such as CRO:s, orthopedics, pharmaceutical companies, physiotherapeutes to prevent OA from developing. By doing this, we will contribute to a more sustainable society by increasing well being and minimizing OA patients in health care.
The construction industry represents a fifth of Sweden’s carbon footprint, creating ten million tons of waste every year. Much of this waste is fully functional material and furniture that could be reused if properly managed. We will make reuse simple by providing a common technical platform for property managers, tenants, and architects. By making all inventory visible, trackable, and accessible, we can ensure that the lifespan of furnishings is maximized.
Seeing a child grow up to be a healthy person is a number one priority for young parents, yet help is limited and knowledge resources are vast and complicated. This is especially crucial in the infant to toddler stages of the development.
cactus. has the purpose of helping young parents measure their child’s growth, gain understanding into risk factors and give recommendations on how to avoid these risks. Through a smart algorithm and continuous improvements based on research in cooperation with Barnklinik Halmstad, we hope to give parents a piece of helpful tools to nurture a healthy growth.
Glenntec combines the superior performance of graphene with infrastructural materials to produce more tolerant, durable and sustainable surfaces. Glenntec aims to improve the longevity of roads, minimizing costs of maintenance and resurfacing. With longer lasting road surfaces, less energy and raw materials will be required to maintain our highways, urban areas, airports and harbours. Glenntec paves the way for a better future.
Harmonica is an Augmented Reality tool made for improving laparoscopic liver surgery and the removal of liver tumours. Today, tumour removal is mainly done non-invasively i.e. laparoscopic surgery. However, surgeons face a big challenge when operating through a limited point of view, trying to orient themselves on such a homogenous organ as the liver. By using existing gadgets and screens in the surgery room, Harmonica is a tool that provides a livestream augmented image on top of the already existing image provided by the laparoscopic camera. This is helping surgeons to orient themselves during the surgery enabling them to locate and remove the tumour it in the most safe way.
Our team of researchers, medical doctors, engineers, and business developers are working on technologies to digitalize and streamline diagnostics in healthcare, both in terms of resources and results, with the use of artificial intelligence. We are currently developing multiple different algorithms that will make the diagnosis of certain diseases faster, cheaper, more accurate, and less wasteful. By this we aim to achieve screening and diagnostics to a broader range of patients at an earlier stage, with higher accuracy.
Finding the optimal compositions within the development of new materials is often like finding a needle in a haystack. Svala Technologies offers R&D-departments and computational consultancy firms the equivalent of a metal detector to find the needle in that haystack. Our patent pending technology removes the need for trial-and-error in R&D-processes by simulating molecular dynamics compositions. Together we enable the development of innovative, optimal and sustainable new materials.
Videm is developing a portable virus detection device which enables rapid and reliable genetic analysis of DNA to detect, identify and monitor infectious diseases. Videm can be used directly at the point-of-care with a total diagnostic test time of less than an hour, without the need for advanced bioanalytical laboratories. By using a linear amplification method, compared to exponential methods such as PCR, we minimize the risk of false-negative and false-positive results which is of utmost importance to hinder the spread of infectious diseases and prevent pandemics. Our patent pending technology builds on state-of-the-art bio- and nanotechnology through a research collaboration between Chalmers University of Technology, Stockholm University/SciLifeLab, Karolinska Institutet, Uppsala University and RISE, Research Institute of Sweden.